Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 18 of 34)
- Relevance
  Sort by

Peanut Allergy Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others), By Route of Administration, By Distribution Channel, By Region and Competition

 Report
August 2023
117 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Metastatic Castration-Resistant Prostate Cancer - Pipeline Insight, 2024

 Clinical Trials
December 2024
240 Pages
Global

From

€2730EUR$3,000USD£2,341GBP

Glucagon-Like Peptide 1 Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
104 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Allergic Rhinitis - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Asthma - Competitive landscape, 2023

 Report
April 2023
240 Pages
Global

From

€3185EUR$3,500USD£2,731GBP

Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
330 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Multiple Myeloma - Pipeline Insight, 2024

 Clinical Trials
April 2024
230 Pages
Global

From

€2730EUR$3,000USD£2,341GBP

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
365 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Prostate Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
180 Pages
Global

From

€2730EUR$3,000USD£2,341GBP

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
85 Pages
Global

From

€3185EUR$3,500USD£2,731GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1775EUR$1,950USD£1,521GBP

Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

Basal Cell Neoplasms - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Peanut Allergy - Pipeline Insight, 2024

 Clinical Trials
December 2024
60 Pages
Global

From

€1365EUR$1,500USD£1,170GBP

Ophthalmic Drugs Market by Product Type (Over-The-Counter Drugs, Prescription Drugs), Drug Class (Anti-Allergics, Anti-Glaucoma Agents, Anti-Inflammatories), Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast 2025-2030

 Report
March 2025
180 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

 Report
January 2025
768 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
417 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
4115 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

671 Results (Page 18 of 34)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.